Anavex Life Sciences Email Format

Biotechnology ResearchNew York, United States11-50 Employees

Anavex Life Sciences is a biotechnology research company based in New York City, New York. It focuses on developing therapeutics for central nervous system disorders, including neurodegenerative and neurodevelopmental diseases, as well as pain and various cancers. Its lead candidate, blarcamesine (ANAVEX2-73), is an orally administered therapy designed to restore cellular homeostasis by targeting sigma-1 and muscarinic receptors, and it has progressed through multiple clinical trials in Alzheimer's disease as well as studies in Parkinson's disease dementia and Rett syndrome. The company operates in the biotechnology research industry and is pursuing additional candidates, including ANAVEX3-71, with preclinical data suggesting disease-modifying potential. In 2026, it announced leadership changes, including the appointment of an interim chief executive officer as part of a broader reorganization.

Sign up for free to view info

Company overview Employee directory